ISMA-RHINA 2024
BackPDS1 - Poster Discussion Session – RHINA
Thursday 05 Sep, 11:30 AM -
12:30 PM Helsinki, Finland
Nordia
Poster Session
11:30
P03
Clinical Outcomes and IgA Deficiency in Pediatric Patients: A Retrospective Study in a Tertiary Hospital
11:30
P04
Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis
11:30
P08
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
11:30
P05
Effectiveness of ASA therapy after ASA desensitization on adult N-ERD and CRSwNP patients
11:30
P13
Peripheral blood and urine lipid mediators are associated with NSAID-exacerbated respiratory disease
11:30
P14
Prevalence of asthma as comorbidity in uncontrolled CRSwNP prior to endoscopic sinus surgery – a cross-sectional study
11:30
P06
Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study
11:30
P09
The Influence of Dupilumab on the Nasal and Gastrointestinal Microbiome in Diffuse Type 2 Chronic Rhinosinusitis
11:30
P10
The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis
11:30
P07
Utility of conjunctival allergen challenge in the diagnosis of patients with different phenotypes of allergic rhinitis and conjunctival symptoms
